Recommendations for the prevention and treatment of hepatitis B and C infection in patients on the waiting list for liver transplantation and in liver transplant recipients
Open Access
- 10 September 2020
- journal article
- Published by IPO Association of Transplantologists in Transplantologiya
- Vol. 12 (3), 231-244
- https://doi.org/10.23873/2074-0506-2020-12-3-231-244
Abstract
Рекомендации по профилактике и лечению инфекций вирусами гепатита В и С у больных, находящихся в Листе ожидания трансплантации печени, и реципиентов печениThis publication has 9 references indexed in Scilit:
- Compensation of HCV-associated decompensated cirrhosis treated with modern direct-acting antiviral agentsDokazatel'naya gastroenterologiya, 2019
- EASL Recommendations on Treatment of Hepatitis C 2018Journal of Hepatology, 2018
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceJournal of Hepatology, 2018
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infectionJournal of Hepatology, 2017
- Antiviral therapy for HCV infection in an interferon-free age: shall we treat patients with decompensated cirrhosis before liver transplantation or with recurrent infection of the transplant?Infekcionnye bolezni, 2017
- APASL consensus statements and recommendation on treatment of hepatitis CHepatology International, 2016
- Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World CohortClinical Infectious Diseases, 2015
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International, 2015
- Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virusJournal of Hepatology, 2015